Stem cell therapy trial aims to halt vision loss in dry AMD
NCT ID NCT04627428
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 25 times
Summary
This early-stage trial tests whether transplanting special stem cells into the eye is safe for people with dry age-related macular degeneration (AMD), a leading cause of vision loss. About 18 adults over 55 with dry AMD will receive the cell transplant during eye surgery. The main goal is to check for side effects like vision loss or inflammation, not yet to prove the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Retina Vitreous Associates Medical Group
RECRUITINGBeverly Hills, California, 90211, United States
Contact
-
Spencer Center for Vision Research
RECRUITINGPalo Alto, California, 94303, United States
Contact
-
University of Michigan Kellogg Eye Center
RECRUITINGAnn Arbor, Michigan, 48105, United States
Contact
Conditions
Explore the condition pages connected to this study.